Follow
Xu Kang
Xu Kang
TRI Princeton
Verified email at triprinceton.org
Title
Cited by
Cited by
Year
Anti-inflammatory small molecules to treat seizures and epilepsy: from bench to bedside
A Dey, X Kang, J Qiu, Y Du, J Jiang
Trends in pharmacological sciences 37 (6), 463-484, 2016
2042016
Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype
X Kang, J Qiu, Q Li, KA Bell, Y Du, DW Jung, JY Lee, J Hao, J Jiang
Scientific reports 7 (1), 9459, 2017
532017
Modifying and Taming Photoactive Compounds Using Synthetic Macrocycles as Supramolecular Hosts
X Kang, A Ahmad Dar, R Reddy Mittapalli, A Carrao, A Dawn, H Kumari
ChemistrySelect 8 (30), e202300894, 2023
12023
A novel inclusion complex of oxybenzone with C-methylresorcin [4] arene deters skin permeation
X Kang, A Eisenhart, AA Dar, RR Mittapalli, A Greenwood, L Alsheddi, ...
RSC advances 13 (37), 25846-25852, 2023
2023
Supramolecular modification of commonly used photoactive drugs regarding their photochemistry, stability, and safety
X Kang
University of Cincinnati, 2021
2021
Nanoscience in cosmetics
H Kumari, X Kang, M Mirzamani, A Dawn
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019
2019
Prostaglandin E2 in oxidopamine-induced neuronal inflammation and injury
X Kang
University of Cincinnati, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–7